FDA — authorised 14 December 2012
- Application: NDA200677
- Marketing authorisation holder: RECORDATI RARE
- Status: supplemented
FDA authorised Signifor on 14 December 2012
Yes. FDA authorised it on 14 December 2012; FDA authorised it on 15 December 2014; FDA has authorised it.
RECORDATI RARE holds the US marketing authorisation.